![Zohar Koren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Zohar Koren
Directeur Général chez
SciCann Therapeutics, Inc.
Profil
Dr. Zohar Koren is a Chief Executive Officer at OncoDecipher Ltd., a Chief Technology Officer at Xinteza API Ltd. and a Chief Executive Officer at SciCann Therapeutics, Inc. Dr. Koren was previously employed as a Chief Executive Officer & Director by Cannabics Pharmaceuticals, Inc. and a Founder by Cannabics, Inc. He also served on the board at Alterola Biotech, Inc. (California).
He received his undergraduate degree from The Hebrew University of Jerusalem, a graduate degree from the University of Haifa and a doctorate degree from the University of Haifa.
Postes actifs de Zohar Koren
| Sociétés | Poste | Début |
|---|---|---|
SciCann Therapeutics, Inc.
 SciCann Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Directeur Général | - |
Xinteza API Ltd.
 Xinteza API Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Fondateur | 17/03/2019 |
Oncodecipher
 Oncodecipher Packaged SoftwareTechnology Services Develops a AI powered platform designed to detect and analyze novel genetic variations as biomarkers for therapies | Directeur Général | 01/02/2024 |
Anciens postes connus de Zohar Koren
| Sociétés | Poste | Fin |
|---|---|---|
| CNBX PHARMACEUTICALS INC. | Fondateur | 23/01/2015 |
| ALTEROLA BIOTECH, INC. | Directeur/Membre du Conseil | - |
Cannabics, Inc.
 Cannabics, Inc. Financial ConglomeratesFinance Provides cannabinoid-based therapy through its subsidiary | Fondateur | - |
Formation de Zohar Koren
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
CNBX Pharmaceuticals, Inc.
 CNBX Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer | Health Technology |
Alterola Biotech, Inc. (California)
 Alterola Biotech, Inc. (California) Chemicals: SpecialtyProcess Industries Manufactures medicament containing chewing gums | Process Industries |
Cannabics, Inc.
Cannabics, Inc. Financial ConglomeratesFinance Provides cannabinoid-based therapy through its subsidiary | Finance |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Haifa
 University of Haifa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xinteza API Ltd.
Xinteza API Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Health Technology |
SciCann Therapeutics, Inc.
SciCann Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Oncodecipher
Oncodecipher Packaged SoftwareTechnology Services Develops a AI powered platform designed to detect and analyze novel genetic variations as biomarkers for therapies | Technology Services |
